Fierce Pharma August 31, 2023
It was a year ago this month that President Joe Biden signed the Inflation Reduction Act. While the landmark bill introduces several pricing measures, Democrats on Capitol Hill are still pursuing ways to rein in the pharma industry.
On Thursday, Senators Maggie Hassan (D-N.H.) and Tina Smith (D-Minn.) pressed insulin makers Eli Lilly, Novo Nordisk and Sanofi on their eligibility criteria for inexpensive insulin that the companies have pledged to provide later this year.
Additionally, Rep. Pramila Jayapal (D-Wash.) and Sen. Elizabeth Warren (D-Mass.) have asked the FDA to address “sham patents” that biopharma companies acquire to “hold off generic competition for at least 2.5 years, regardless of the outcome of any litigation.”
In a letter (PDF)...
Today's Sponsors
Today's Sponsor